These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 7865272)

  • 1. Post-transfusion chronic hepatitis C in children.
    Matsuoka S; Tatara K; Hayabuchi Y; Nii M; Mori K; Kuroda Y
    J Paediatr Child Health; 1994 Dec; 30(6):544-6. PubMed ID: 7865272
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serologic, virologic, and histologic characteristics of chronic phase hepatitis C virus disease in children infected by transfusion.
    Matsuoka S; Tatara K; Hayabuchi Y; Taguchi Y; Mori K; Honda H; Itou S; Yuasa Y; Kuroda Y
    Pediatrics; 1994 Dec; 94(6 Pt 1):919-22. PubMed ID: 7971011
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Importance of recall and follow-up screening for chronic hepatitis C in children receiving blood products prior to 1990 in Japan.
    Matsuoka S; Tatara K; Ushiroguchi Y; Kubo M; Nii M; Taguchi Y; Kuroda Y
    Acta Paediatr Jpn; 1994 Aug; 36(4):383-6. PubMed ID: 7524266
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Screening for post-transfusion hepatitis C-importance of enrollment and recall of blood transfusion recipients].
    Matsuoka S
    Nihon Koshu Eisei Zasshi; 1994 Sep; 41(9):933-7. PubMed ID: 7524804
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of screening blood donors for hepatitis C antibody on posttransfusion hepatitis: a prospective study with a second-generation anti-hepatitis C virus assay.
    Huang YY; Yang SS; Wu CH; Shih WS; Huang CS; Chen PH; Lin YM; Shen CT; Chen DS
    Transfusion; 1994 Aug; 34(8):661-5. PubMed ID: 7521077
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low incidence of non-A, non-B post-transfusion hepatitis in London confirmed by hepatitis C virus serology.
    Contreras M; Barbara JA; Anderson CC; Ranasinghe E; Moore C; Brennan MT; Howell DR; Aloysius S; Yardumian A
    Lancet; 1991 Mar; 337(8744):753-7. PubMed ID: 1672391
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of screening for hepatitis C virus in children with malignant disease and who undergo bone marrow transplantation.
    Tada K; Tajiri H; Kozaiwa K; Sawada A; Guo W; Okada S
    Transfusion; 1997 Jun; 37(6):641-4. PubMed ID: 9191826
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Markers of hepatitis C virus infection in Sardinian blood donors: relationship with alanine aminotransferase levels.
    Lai ME; Mazzoleni AP; Farci P; Melis A; Porru A; Orgiana G; Arnone M; Balestrieri A
    J Med Virol; 1993 Dec; 41(4):282-8. PubMed ID: 7508972
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term follow-up of and infectivity in blood donors with hepatitis C antibodies and persistently normal alanine aminotransferase levels.
    Rossini A; Gazzola GB; Ravaggi A; Agostinelli E; Biasi L; Albertini A; Radaeli E; Cariani E
    Transfusion; 1995 Feb; 35(2):108-11. PubMed ID: 7529954
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison of hepatitis C virus (HCV)-RNA and--antibody as markers of infection and predictors of infectivity.
    Beardsley AM; LaBrooy JT; Rozen L; Gowans EJ
    Aust N Z J Med; 1994 Apr; 24(2):182-7. PubMed ID: 8042947
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronic hepatitis C virus infection after treatment for pediatric malignancy.
    Cesaro S; Petris MG; Rossetti F; Cusinato R; Pipan C; Guido M; Masiero L; Botta GA; Meloni GA; Zanesco L
    Blood; 1997 Aug; 90(3):1315-20. PubMed ID: 9242567
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incidence of non-A, non-B hepatitis after screening blood donors for antibodies to hepatitis C virus and surrogate markers.
    Barrera JM; Bruguera M; Ercilla MG; Sánchez-Tapias JM; Gil MP; Costa J; Gelabert A; Rodés J; Castillo R
    Ann Intern Med; 1991 Oct; 115(8):596-600. PubMed ID: 1909848
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcome of an optional HCV screening program for blood transfusion recipients in Ireland.
    Davoren A; Dillon AD; Power JP; Donnellan J; Quinn JM; Willis JW; Lawlor EM; O'Riordan JM
    Transfusion; 2002 Nov; 42(11):1501-6. PubMed ID: 12421225
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High rate of infectivity and liver disease in blood donors with antibodies to hepatitis C virus.
    Esteban JI; López-Talavera JC; Genescà J; Madoz P; Viladomiu L; Muñiz E; Martin-Vega C; Rosell M; Allende H; Vidal X
    Ann Intern Med; 1991 Sep; 115(6):443-9. PubMed ID: 1651674
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of hepatitis-C virus infection in children with chronic post-transfusion hepatitis.
    Puchhammer-Stöckl E; Hofmann H; Fink FM; Mor W; Höcker-Schulz S; Heinz FX; Kunz C
    J Med Virol; 1992 Aug; 37(4):298-302. PubMed ID: 1328503
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatitis C virus infection in volunteer blood donors in Taiwan. Evaluation by hepatitis C antibody assays and the polymerase chain reaction.
    Wang JT; Wang TH; Sheu JC; Tsai SJ; Hsieh YS; Lin DT; Wang CY; Chen DS
    Arch Pathol Lab Med; 1993 Feb; 117(2):152-6. PubMed ID: 8381269
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictive value of screening tests for persistent hepatitis C virus infection evidenced by viraemia. Japanese experience.
    Watanabe J; Matsumoto C; Fujimura K; Shimada T; Yoshizawa H; Okamoto H; Iizuka H; Tango T; Ikeda H; Endo N
    Vox Sang; 1993; 65(3):199-203. PubMed ID: 7504373
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of antibodies to hepatitis C virus in a study of transfusion-associated hepatitis.
    Esteban JI; González A; Hernández JM; Viladomiu L; Sánchez C; López-Talavera JC; Lucea D; Martin-Vega C; Vidal X; Esteban R
    N Engl J Med; 1990 Oct; 323(16):1107-12. PubMed ID: 2170839
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatitis C virus RNA in serum of blood donors with or without elevated transaminase levels.
    Romeo R; Thiers V; Driss F; Berthelot P; Nalpas B; Brechot C
    Transfusion; 1993 Aug; 33(8):629-33. PubMed ID: 7688157
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incidence of post-transfusion hepatitis before and after screening for hepatitis C virus antibody.
    Wang YJ; Lee SD; Hwang SJ; Chan CY; Chow MP; Lai ST; Lo KJ
    Vox Sang; 1994; 67(2):187-90. PubMed ID: 7528456
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.